HT Hospital Technologies agreement calls for minimum sales of 150,000 units the first year, 200,000 units the second, and 250,000 units the third year.
Robert McCullough, CEO of CytoCore, said: “Franco Pappa, president of MOSS continues to demonstrate his support and enthusiasm for the SoftPAP Collector by expanding his distribution territory from Italy to include Switzerland as well. We expect to receive an initial order to ship first SoftPAP products to Switzerland by mid-April.”